9th Mar. ,2021
OBiO and QuaCell Biotechnology reached a strategic cooperation on the joint development of the Wayne293™ host cell platform and high-toxin-producing derivative cell lines
On March 9, 2021, OBiO Technology (Shanghai) Corp., Ltd. and QuaCell Biotechnology, Co., Ltd. jointly announced a strategic cooperation intent on the joint development of the Wayne293™ host cell platform and high-toxin-producing derivative cell lines.
